$21.12
+0.08 (+0.38%)
Open$21.12
Previous Close$21.04
Day High$21.20
Day Low$21.02
52W High$25.15
52W Low$16.52
Volume—
Avg Volume832.5K
Market Cap1.51B
P/E Ratio4.21
EPS$4.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+85.4% upside
Current
$21.12
$21.12
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 345.95M | 321.88M | 296.49M |
| Net Income | 228.06M | 190.97M | 100.45M |
| Profit Margin | 65.9% | 62.6% | 33.9% |
| EBITDA | 149.45M | 132.10M | 161.71M |
| Free Cash Flow | — | — | 84.32M |
| Rev Growth | +7.5% | +7.5% | +12.4% |
| Debt/Equity | 0.22 | 0.22 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |